Alimera Sciences, Inc.
USD5.54
-0.01 (-0.18%)
CEO
Richard S. Eiswirth Jr.
IPO Date
2019-11-04
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
US
Open
$5.55
Prev. Close
$5.55
Day Low
$5.53
Day High
$5.56
52W Low
$2.61
52W High
$5.65
Market Cap
$0.30B
Volume
2.68M
| -1.0 |
| 31 Dec 2021 | FY | 88.1% | -7.4% | 167.8% | -7.5% | -16.73 | 3.35 | -7.7 |
| 31 Dec 2020 | FY | 86.3% | -10.5% | 66.9% | -10.5% | -5.64 | 2.83 | -4.0 |
| 31 Dec 2019 | FY | 87.7% | -19.4% | 234.9% | -20.8% | -8.88 | 2.72 | -3.5 |
| 31 Dec 2018 | FY | 90.0% | -34.9% | -601.8% | -30.3% | 14.11 | 3.41 | -3.9 |
| 31 Dec 2017 | FY | 90.4% | -61.3% | -147.5% | -36.7% | 2.35 | 4.07 | -4.0 |
| 31 Dec 2016 | FY | 93.2% | -96.6% | -129.7% | -47.2% | 1.31 | 5.20 | -1.7 |
| 31 Dec 2015 | FY | 92.1% | -136.6% | -116.4% | -43.5% | 1.24 | 1.13 | -3.5 |
| 31 Dec 2014 | FY | 82.9% | -426.3% | -72.5% | -32.8% | 0.69 | 7.95 | -6.2 |
| -8.4 |
| 31 Dec 2023 | Q4 | 86.2% | -14.4% | -8.2% | -2.5% | 1.46 | 2.39 | -15.5 |
| 30 Sept 2023 | Q3 | 74.7% | -5.8% | -2.8% | -0.9% | 1.32 | 2.73 | -18.4 |
| 30 Jun 2023 | Q2 | 86.2% | -57.2% | -21.7% | -6.5% | 1.39 | 3.23 | -0.6 |
| 31 Mar 2023 | Q1 | 85.0% | -36.7% | 26.3% | -10.3% | -2.35 | 2.52 | -0.7 |
| 31 Dec 2022 | Q4 | 84.9% | -26.9% | 18.1% | -8.9% | -2.13 | 0.74 | -1.3 |
| 30 Sept 2022 | Q3 | 85.2% | -38.7% | 29.1% | -12.1% | -2.44 | 0.88 | -1.7 |
| 30 Jun 2022 | Q2 | 85.2% | -21.3% | 25.3% | -6.5% | -3.55 | 1.30 | -3.1 |
| 31 Mar 2022 | Q1 | 85.9% | -50.1% | 69.2% | -11.9% | -5.07 | 2.04 | -1.6 |